What happens when NSAIDs injure the small bowel and cause hidden bleeding, ulcers, protein loss, or diaphragm-like strictures beyond the reach of routine EGD?
Marcus’s path through medication review, small-bowel diagnosis, treatment, safer pain planning, and follow-up
Your guardians. GastroDoxs GutGuardians™ is our team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
A 47-year-old energy-sector project director navigating NSAID enteritis
Marcus developed recurrent right-lower abdominal pain, loose stool, and mild iron deficiency while taking high-dose ibuprofen for a sports injury.
Colonoscopy showed patchy terminal ileal erosions and shallow ulcers, leading to an initial concern for Crohn’s disease.
MR enterography did not show fistulas, penetrating disease, or convincing chronic transmural inflammation, and biopsy lacked a specific Crohn’s pattern.
His Houston journey focused on stopping NSAIDs, repeating objective assessment after a healing interval, and avoiding premature lifelong immunosuppression when the lesions resolved.
The ileal ulcers looked inflammatory, but the medication history and healing after NSAID withdrawal showed why Crohn’s disease could not be diagnosed from one endoscopic pattern.
Marcus’s symptoms began during a period of unusually heavy NSAID exposure.
Terminal ileitis made Crohn’s disease an important but not exclusive possibility.
The absence of typical chronic complications and the medication timeline kept NSAID injury high in the differential.
Resolution after withdrawal supplied important longitudinal evidence.
The turning point came when Marcus understood that the small-bowel injury needed to be linked to medication exposure, lesion pattern, competing diagnoses, and complication risk.
Marcus expected to start biologic therapy immediately after seeing ileal ulcers.
The GI team explained that NSAID injury can produce erosions, ulcers, inflammation, and strictures that overlap with Crohn’s disease.
The pathology, enterography, inflammatory markers, perianal history, and medication exposure were reviewed together.
Because he was clinically stable, NSAID withdrawal and planned reassessment were safer than committing to a lifelong IBD diagnosis without adequate support.
Persistent or progressive inflammation after withdrawal would have strengthened the Crohn’s pathway.
The plan had to establish whether NSAIDs truly explained the small-bowel findings, determine whether bleeding or obstruction was present, and create a workable alternative pain or cardiovascular strategy.
The Houston-area team reviewed chronic diarrhea, weight loss, perianal symptoms, family history, extraintestinal features, and prior episodes.
Dose, duration, combinations, and timing relative to symptoms were reconstructed.
Strictures, mural thickening, fistulas, abscesses, and broader small-bowel disease were evaluated.
The patient received a defined interval for symptom, laboratory, and endoscopic or imaging reassessment after NSAID withdrawal.
GastroDoxs can review NSAID exposure, iron-deficiency anemia, occult bleeding, diarrhea, low albumin, capsule findings, enterography, stricture risk, and safer medication options.
The pathway moved from anemia, diarrhea, pain, or obstruction to NSAID exposure review, small-bowel testing, withdrawal of the causative medicine, and treatment of complications.
Marcus’s symptoms began during a period of unusually heavy NSAID exposure.
Review NSAID enteritis →Terminal ileitis made Crohn’s disease an important but not exclusive possibility.
Review abdominal pain →Strictures, mural thickening, fistulas, abscesses, and broader small-bowel disease were evaluated.
Review capsule endoscopy →The suspected cause was removed before escalating to IBD-directed immunosuppression.
Schedule Houston follow-up →The pathway depends on NSAID exposure, bleeding, anemia, diarrhea, protein loss, suspected stricture, obstruction risk, and whether Crohn’s disease or another small-bowel disorder remains plausible.
The Houston-area team reviewed chronic diarrhea, weight loss, perianal symptoms, family history, extraintestinal features, and prior episodes.
Dose, duration, combinations, and timing relative to symptoms were reconstructed.
Strictures, mural thickening, fistulas, abscesses, and broader small-bowel disease were evaluated.
The suspected cause was removed before escalating to IBD-directed immunosuppression.
Iron was replaced and blood counts were monitored.
Suspected small-bowel stricture changes capsule-endoscopy safety. Persistent vomiting, marked distension, heavy bleeding, or severe pain requires urgent evaluation.
NSAID dose and duration, lesion distribution, bleeding, anemia, protein loss, stricture risk, imaging, capsule findings, pathology, and competing diagnoses are interpreted together.
Both can cause terminal ileal erosions, ulcers, pain, diarrhea, bleeding, and stricturing.
Transmural disease, fistulas, perianal disease, persistent skip inflammation, and chronic histology support Crohn’s more strongly.
Recent or prolonged NSAID use can materially change interpretation of otherwise nonspecific ileitis.
Healing after NSAID discontinuation argues against active chronic IBD when the rest of the evidence is weak.
Biologics and steroids should not be started solely because NSAID-associated ileitis looks inflammatory.
The consultation connected medication exposure with the exact small-bowel consequence and the safest diagnostic and treatment sequence.
The Houston-area team reviewed chronic diarrhea, weight loss, perianal symptoms, family history, extraintestinal features, and prior episodes.
Dose, duration, combinations, and timing relative to symptoms were reconstructed.
Ulcer pattern, chronicity, granulomas, crypt changes, and colon involvement were assessed.
Strictures, mural thickening, fistulas, abscesses, and broader small-bowel disease were evaluated.
The patient received a defined interval for symptom, laboratory, and endoscopic or imaging reassessment after NSAID withdrawal.
Treatment removes ongoing NSAID injury when possible, corrects bleeding or nutritional consequences, and treats established strictures or complications separately.
The suspected cause was removed before escalating to IBD-directed immunosuppression.
Analgesia was redesigned around non-NSAID options where medically appropriate.
Iron was replaced and blood counts were monitored.
Persistent lesions after an adequate withdrawal period would prompt renewed Crohn’s evaluation.
Treatment would follow the Crohn’s phenotype if longitudinal evidence ultimately supported it.
Severe pain, persistent vomiting, overt bleeding, or systemic illness required prompt care.
NSAID enteropathy may require gastroenterology, pain management, cardiology, advanced endoscopy, nutrition, hematology, or surgery depending on the complication.
The Houston-area team reviewed chronic diarrhea, weight loss, perianal symptoms, family history, extraintestinal features, and prior episodes.
Strictures, mural thickening, fistulas, abscesses, and broader small-bowel disease were evaluated.
The patient received a defined interval for symptom, laboratory, and endoscopic or imaging reassessment after NSAID withdrawal.
Iron was replaced and blood counts were monitored.
Stable care can include medication-risk review, iron and nutrition monitoring, small-bowel test interpretation, and coordination with pain, cardiology, advanced endoscopy, or surgery when needed.
10425 Huffmeister Road, Suite 280, Houston, TX 77065
Monday to Friday, 7:00 AM to 7:00 PM
Houston, Bear Creek, Spring Branch, Copperfield, Willowbrook, and northwest Houston
Huffmeister Road, Beltway 8, Highway 6, and US-290
Coverage may differ for GI consultation, CBC and iron studies, capsule endoscopy, patency capsule, CT/MR enterography, device-assisted enteroscopy, endoscopic dilation, and surgery.
Include over-the-counter and prescription drugs, combination medicines, dose, frequency, and duration.
Provide CBC, ferritin, iron studies, albumin, weight trend, and transfusion history.
Capsule, enterography, EGD, colonoscopy, enteroscopy, and prior operative reports can change the next step.
Arthritis, cardiovascular disease, chronic pain, and other indications affect whether the medicine can safely be stopped.
The decision matched lesion type, bleeding or obstruction severity, NSAID necessity, alternative diagnoses, and the consequences of continued exposure.
Both can cause terminal ileal erosions, ulcers, pain, diarrhea, bleeding, and stricturing.
Transmural disease, fistulas, perianal disease, persistent skip inflammation, and chronic histology support Crohn’s more strongly.
Strictures, mural thickening, fistulas, abscesses, and broader small-bowel disease were evaluated.
The suspected cause was removed before escalating to IBD-directed immunosuppression.
NSAID small-bowel injury can look very different depending on whether the dominant problem is bleeding, inflammation, protein loss, or fibrosis.
Capsule endoscopy may show reddened folds, erosions, denuded areas, or ulcers causing pain or occult bleeding.
Best for: Patients with unexplained anemia or small-bowel symptoms after routine endoscopy
Limitations: Findings can overlap with Crohn’s disease and other enteropathies
Takeaway: Interpret lesions with medication exposure and the full differential
Chronic small-bowel blood loss can present mainly as falling ferritin or hemoglobin.
Best for: Patients with unexplained iron deficiency after upper and lower GI evaluation
Limitations: Other small-bowel bleeding sources must be excluded
Takeaway: The absence of visible blood does not exclude NSAID injury
Diffuse inflammation can contribute to enteric protein loss and hypoalbuminemia.
Best for: Patients with edema, low albumin, diarrhea, and compatible NSAID exposure
Limitations: Liver, kidney, heart, nutrition, and other enteropathies must be excluded
Takeaway: Treat the cause, not only the edema
Fibrotic ring-like narrowing can cause recurrent partial or complete small-bowel obstruction.
Best for: Long-term NSAID users with obstructive symptoms and short multifocal stenoses
Limitations: Capsule retention risk and need for intervention are higher
Takeaway: Assess patency before capsule and treat fixed narrowing separately
Heavy bleeding, obstruction, perforation, severe anemia, or dehydration can turn a chronic medication injury into an emergency.
How the NSAID-induced ileitis and small-bowel ulcers initially mistaken for Crohn’s disease journey changed medication use, small-bowel symptoms, and follow-up
The suspected cause was removed before escalating to IBD-directed immunosuppression.
Analgesia was redesigned around non-NSAID options where medically appropriate.
Treatment would follow the Crohn’s phenotype if longitudinal evidence ultimately supported it.
Marcus returned to daily responsibilities with a clearer understanding of which pain or cardiovascular medicines carried small-bowel risk and why medication changes needed coordination.
The patient also knew that new bleeding, severe pain, vomiting, or distension required prompt reassessment.
The ileal ulcers looked inflammatory, but the medication history and healing after NSAID withdrawal showed why Crohn’s disease could not be diagnosed from one endoscopic pattern.
This Houston patient journey is an educational composite illustrating NSAID-induced ileitis and small-bowel ulcers initially mistaken for Crohn’s disease. It does not represent a specific patient. NSAID enteritis can cause small-bowel erosions, ulcers, occult or overt bleeding, protein loss, diaphragm-like strictures, obstruction, and rarely perforation. Diagnosis requires medication review and exclusion of other small-bowel disorders. Stopping an NSAID or aspirin may be unsafe when it is medically essential, so medication changes should be coordinated with the prescribing clinician. Heavy bleeding, severe pain, persistent vomiting, marked distension, fainting, or fever with worsening illness requires prompt medical assessment.
Answers about small-bowel NSAID injury, anemia, capsule endoscopy, diaphragm disease, Crohn’s mimics, aspirin, misoprostol, PPIs, and urgent warning signs
NSAID enteritis is injury to the small intestine caused by nonsteroidal anti-inflammatory drugs such as ibuprofen, naproxen, diclofenac, or aspirin. It can produce erosions, ulcers, bleeding, protein loss, strictures, and rarely perforation.
GastroDoxs provides planned GI consultation at 10425 Huffmeister Road, Suite 280, Houston, TX 77065. Published office hours are Monday through Saturday, 8:00 AM to 5:00 PM.
Many patients have few symptoms. Others develop abdominal pain, diarrhea, iron-deficiency anemia, occult or overt bleeding, low albumin, weight loss, or obstructive symptoms.
Diagnosis uses medication history plus exclusion of competing causes and may involve capsule endoscopy, CT or MR enterography, device-assisted enteroscopy, laboratory testing, or surgery depending on the presentation.
It is a rare complication in which thin fibrotic ring-like strictures form in the small bowel and can cause partial or complete obstruction.
Capsule endoscopy is useful for mucosal lesions and obscure small-bowel bleeding, but suspected strictures should be assessed first because the capsule can become retained.
When medically possible, stopping the causative NSAID is foundational. Iron, nutrition, bleeding treatment, alternative pain therapy, and treatment of strictures are added according to the problem.
Misoprostol has evidence for healing aspirin-associated small-bowel ulcers in selected patients who must continue aspirin, but it is not a universal treatment and can cause diarrhea or cramping.
Yes. Both can cause ileitis, erosions, ulcers, bleeding, and strictures, so medication exposure, pathology, imaging, chronicity, and response after NSAID withdrawal matter.
Seek urgent care for heavy bleeding, black tarry stool with weakness, severe pain, persistent vomiting, marked distension, inability to pass gas or stool, fainting, or fever with worsening illness.
Explore related condition, symptom, and procedure guides connected with NSAID enteropathy.
Review causes, bleeding, ulcers, protein loss, diaphragm disease, diagnosis, and treatment.
Condition Guide →Review GI causes of chronic blood loss and when small-bowel evaluation is considered.
Anemia Guide →Understand vomiting, distension, cramping, and urgent evaluation of obstructive symptoms.
Obstruction Guide →Learn how capsule endoscopy evaluates small-bowel mucosal disease and bleeding.
Capsule Guide →Arrange stable review of NSAID exposure, anemia, capsule findings, enterography, and small-bowel complications.
Book Houston Appointment →Document every prescription and over-the-counter NSAID or aspirin, dose, duration, indication, and combination use.
Determine whether the dominant issue is occult bleeding, ulceration, diarrhea, protein loss, stricture, or obstruction.
Use capsule endoscopy for mucosal disease when appropriate and enterography or patency assessment when narrowing is suspected.
The suspected cause was removed before escalating to IBD-directed immunosuppression.
Iron was replaced and blood counts were monitored.
Severe pain, persistent vomiting, overt bleeding, or systemic illness required prompt care.
GastroDoxs can review NSAID exposure, iron-deficiency anemia, occult bleeding, low albumin, capsule findings, enterography, stricture risk, and safer medication strategies.